Compare COEP & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COEP | GECC |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 107.8M |
| IPO Year | N/A | N/A |
| Metric | COEP | GECC |
|---|---|---|
| Price | $14.76 | $7.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 97.1K | ★ 119.1K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 22.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $500,996.00 | ★ $46,553,000.00 |
| Revenue This Year | N/A | $32.16 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.68 |
| 52 Week Low | $3.80 | $6.61 |
| 52 Week High | $21.41 | $11.46 |
| Indicator | COEP | GECC |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 41.66 |
| Support Level | $13.88 | $6.85 |
| Resistance Level | $15.12 | $7.16 |
| Average True Range (ATR) | 0.83 | 0.23 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 78.91 | 56.36 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.